References
- Alber, H.F., Wanitschek, M.M., de Waha, S., Ladurner, A., Suessenbacher, A., Dorler, J., Dichtl, W., Frick, M., Ulmer, H., Pachinger, O., Weidinger, F. (2008). High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography. Eur. J. Clin. Invest., 38(6), 372-380.10.1111/j.1365-2362.2008.01954.x
- Alberti, K.G.M., Zimmet, P., Shaw, J. (2005). The metabolic syndrome — a new world wide definition. Lancet, 366, 1059-1062.10.1016/S0140-6736(05)67402-8
- Berg, A.H., Scherer, P.E. (2005). Adipose tissue, inflammation, and cardiovascular disease. Circ. Res., 96, 939-949.10.1161/01.RES.0000163635.62927.3415890981
- Bilgili, S.C.A., Dogan, A., Karaca, B. (2008). Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocr. Regul., 42(1), 63-68.
- Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, F., Zenere, M.B., Monauni, T., Muggeo, M. (2000). Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23(1), 57-63.10.2337/diacare.23.1.5710857969
- Caglayan, E.C., Blaschke, F., Takata, Y., Hsueh, W.A. (2005). Metabolic syndrome — interdependence of the cardiovascular and metabolic pathways. Curr. Opin. Pharmacol., 5, 135-142.10.1016/j.coph.2005.01.00815780821
- Calabro, P., Limongelli, G., Pacileo, G., Di Salvo, G., Golino, P. (2008). The role of adiposity as a determinant of an inflammatory milieu. J. Cardiovasc. Med., 9(5), 450-460.10.2459/JCM.0b013e3282eee9a818403996
- Calabro, P., Yeh, E.T.H. (2008). Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight into global cardiometabolic risk. Curr. Hypertens. Rep., 10, 32-38.10.1007/s11906-008-0008-z18367024
- El-Menyar, A.A. (2008). Cytokines and coronary artery disease: The state of the art. Crit. Pathw. Cardiol., 7(2), 139-151.10.1097/HPC.0b013e31816713d918520532
- Espinola-Klein, Ch., Rupprecht, H.J., Bickel, Ch., Lackner, K., Genth-Zotz, S., Post, F., Munzel, T., Blankenberg, S. (2008). Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome. Eur. J. Cardiovasc. Prev. Rehab., 15, 278-284.10.1097/HJR.0b013e3282f37a6e18525381
- Florentin, M., Liberopoulus, E.N., Wierzbicki, A.S., Mikhailidis, D.P. (2008). Multiple actions of high-density lipoprotein. Curr. Opin. Cardiol., 23, 370-378.10.1097/HCO.0b013e328304380618520722
- Fuster, V., Sanz, J. (2008). Atherothrombosis: Past, present and future. Revista Argentina de Cardiologia, 76, spec. ed., 51-54.
- Gimeno, R.E., Klaman, L.D. (2005). Adipose tissue as an active endocrine organ: Recent advances. Curr. Opin. Pharmacol., 5, 122-128.10.1016/j.coph.2005.01.006
- Ikonomidis, I., Stamatelopoulos, K., Lekakis, J., Vamvakou, G.D., Kremastinos, D.Th. (2008). Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease. Atherosclerosis, 199, 3-11.10.1016/j.atherosclerosis.2008.02.019
- Kahn, R., Buse, J., Ferrannini, E., Stern, M. (2005). The metabolic syndrome: Time for a critical cppraisal. Diabetes Care, 28(9), 2289-2304.10.2337/diacare.28.9.2289
- Khera, A., Mc Guire, D.K., Murphy, A.S., Stanek, H.S., Das, S.R., Vongpatanasin, W., Wians, F.H., Jr, Grundy, S.M., Lemos, J.A. (2005). Race and gender differences in C-reactive protein levels. J. Amer. Coll. Cardiol, 46(3), 464-469.10.1016/j.jacc.2005.04.051
- Lago, F., Diequez, C., Gomez-Reino, J., Gualillo, O. (2007). Adipokines as emerging mediators of immune response and inflammation. Nat. Clin. Practice Rheumatol., 3(12), 716-725.10.1038/ncprheum0674
- Matsuzawa, Y. (2006). The metabolic syndrome and adipocytokines. FEBS Letters, 580, 2917-2921.10.1016/j.febslet.2006.04.028
- Miles, E.A., Rees, D., Banerjee, T., Cazzola, R., Lewis, S., Wood, R., Oates, R., Tallant, A., Cestaro, B., Yaqoob, P., Wahle, K.W., Calder, P.C. (2008). Age related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis, 196, 298-305.10.1016/j.atherosclerosis.2006.11.002
- Nilson, J. (2005). CRP-marker or marker of cardiovascular disease? Arterioscler. Thromb. Vasc. Biol., 25, 1527-1528.10.1161/01.ATV.0000174796.81443.3f
- Pi-Sunyer, F.X. (2006). The relation of adipose tissue to cardiometabolic risk. Clin. Cornerstone, 8 (Suppl. 4), S14-S23.10.1016/S1098-3597(06)80040-2
- Rosenson, R.S. (2005). New approaches in the intensive management of cardiovascular risk in the metabolic syndrome. Curr. Probl. Cardiol., 30(5), 241-280.10.1016/j.cpcardiol.2004.10.00115829899
- Ross, R. (1999). Atherosclerosis — An inflammatory disease. New Engl. J. Med., 340, 115-126.10.1056/NEJM1999011434002079887164
- Saltevo, J., Vanhala, M., Kautiainen, H., Kumpusalo, F., Laakso, M. (2008). Gender difference in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in metabolic syndrome: A population-based study. Diabetes Med., 25(6), 747-750.10.1111/j.1464-5491.2008.02440.x18435780
- Taeye, B.D., Smith, L.H., Vaughan, D.E. (2005). Plasminogen activator inhibitor-1 a common denominator in obesity, diabetes and cardiovascular disease. Curr. Opin. Pharmacol., 5, 149-154.10.1016/j.coph.2005.01.00715780823
- Virani, S.S., Polsani, V.R., Nambi, V. (2008). Novel markers of inflammation in atherosclerosis. Curr. Atheroscl. Rep., 10(2), 164-170.10.1007/s11883-008-0024-018417072